Entirely possible that R2000 has done other projects and simply made the account here in 2013, forgot about it, then came back.

Almost 2 years since those projects were announced, only 1 has been launched. I wonder if the others will even launch. https://www.worldcommunitygrid.org/about_us/viewNewsArticle.do?articleId=558

Just can't give it up, can you? This thread is about COVID-19, not climate projects, so not sure why climate projects are being mentioned. If you feel that "kept-in-the-dark approach" is being done, please send a note to the WCG team. It would be interesting to see if you get response.

CJSL

Crunching on the thin ice of a new day....

Let's be honest here...this project is still a week to 10 days away from launch. By the time it starts, and millions of WUs have been returned to researchers, data analyzed, and promising compounds identified and tested, you will either be dead or immune (by either getting it or vaccine). This project is not looking for a vaccine but a treatment based on docking to viral proteins. There is one company already gearing up it's phase II clinical trial of a vaccine after completing dosing for phase I which indicates to me a vaccine will mostly likely be available before anything comes out of this research. Once 50% of the population has immunity one way or another, what pharmaceutical company is going to want to invest in developing a treatment drug? There won't be much of a market for it. I'll crunch just to get the badge, not because there will be any practical scientific value derived from the docking experiments. Pessimistically speaking of course....

Again, to be honest, there would probably be more usable, practical scientific value resulting from the climate projects

What are the odds that the viral protein would be the same? if not, then you have to do the docking again.
Additionally, are we doing this all over again:
Using Summit, researchers were able to simulate 8,000 compounds in a matter of days to model which could impact that infection process by binding to the virus’s spike, and have identified 77 small-molecule compounds, such as medications and natural compounds, that have shown the potential to impair COVID-19’s ability to dock with and infect host cells.

But, let's say for instance, we are going to use the 30 million database to dock against the protein, it won't be done in days. CEOs of companies developing vaccines are up against the clock and are worried that since the virus is spreading so quickly they won't have any subjects that haven't already been infected to use for testing the vaccine.